Announcing the first international, phase 3 MND clinical trial to be offered across multiple locations in New Zealand.

https://www.mndresearch.auckland.ac.nz/2022/08/03/lighthouse-ii-project-triumeq-in-als-mnd/

Sidebar

MND Research Network Newsletters 2022
Best practice guidelines published for MND care in NZ
Prof. Chris Shaw lecture “Gene therapy strategies for MND” available to view now!
Announcing the first international, phase 3 MND clinical trial to be offered across multiple locations in New Zealand.
MND; Who develops it, why, and what we are doing about it?| Webinar
Research Network News
New Zealand genetic frontotemporal dementia study
The 150-year-old mystery disease killing two New Zealanders a week
Motor Neuron Disease Mortality Rates in New Zealand 1992-2013

Lessons from the HEALEY adaptive platform trial in amyotrophic lateral sclerosis - Friday, November 1, 2024
A click-based electrocorticographic brain-computer interface enables long-term high-performance switch scan spelling - Tuesday, October 22, 2024
Altered muscle cholesterol transport in ALS - Monday, October 14, 2024
Examining the complex Interplay between gut microbiota abundance and short-chain fatty acid production in amyotrophic lateral sclerosis patients shortly after onset of disease - Tuesday, October 8, 2024